Maybe they were unable to issue a thumbs up to the S-1(s) while this issue hung around, because they would be effectively authorizing something the court said they couldn't?
Interesting that the lack of Excellagen sales was a factor in the court determining Generex could not be subjected to this injunction!
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links